PADI4 and cervical cancer: Next, we assessed cervical cancer vs. NILM for protein expression levels of PADs 2 and 4, the two PAD isozymes most broadly expressed in human cancer (Yuzhalin, 2019; Sarnik and Makowska, 2022).